Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 6 to 12

Combining atropine eye drops with defocus DIMS for controlling myopia in children

Official title: Efficacy and Safety of Low-concentration Atropine Eye Drops (0.02%, 0.04%) Combined With Defocus Incorporated Multiple Segments (DIMS) for Moderate and High Myopia Control

Run by Tianjin Medical University Eye Hospital · NCT06523504 · Data updated 2026-11-12

This study is testing if using atropine eye drops together with special glasses can help children aged 6 to 12 with moderate to high myopia see better and slow down their eye growth.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment410 (estimated)
SponsorTianjin Medical University Eye Hospital
Academic / other
Locations1 site (Tianjin, Tianjin Municipality)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedMarch 31, 2026
Study endsMarch 31, 2026
Registry record updatedSeptember 8, 2025
Trial IDNCT06523504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are school-age children aged 6 to 12 years with moderate to high myopia.

Probably not a fit

Patients currently using other myopia control methods or with certain eye conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness and safety of low concentration atropine eye drops combined with defocus DIMS in controlling axial length and refraction in children aged 6 to 12 with moderate to high myopia. A total of 410 participants will be randomly assigned to one of five treatment groups using stratified block randomization across multiple centers. The study aims to determine the best approach for managing myopia progression in this age group through a multicenter design.

Why it matters

Potential benefit: If successful, this study could provide a new effective treatment option for controlling myopia progression in children.

How similar studies have gone: Other studies have shown promise in using atropine for myopia control, but this specific combination approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* School-age children aged 6 to 12 years (including boundary value)
* Children with moderate or high myopia (subjective refraction after cycloplegia: -9.00D≤spherical equivalent (SE)≤-3.00D, with-rule astigmatism (C)≤2.00D, against-rule astigmatism (C)≤1.00D, anisometropia of both eyes≤2.50D)
* Binocular best corrected visual acuity (BCVA)≥0.8 (five-point visual acuity 4.9)
* Agree with the study scheme and sign the informed consent
* Note: if both eyes meet the inclusion criteria, the eye with higher spherical equivalent is the study eye; if one eye meets the inclusion criteria, the eye is the study eye.

Exclusion Criteria:

* Used or currently using orthokeratology, multifocal contact lenses, defocusing framework lenses, atropine eye drops and other myopia control means in the past month; used red light treatment in the past
* Children with obvious strabismus and amblyopia
* With congenital eye disease, such as congenital cataract, congenital retinal disease
* Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
* Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
* Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
* Bnormal intraocular pressure and clinical significance (IOP \<10 mmHg or IOP \>21mmHg or binocular IOP difference ≥5mmHg)
* Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
* Optic nerve damage or congenital optic nerve dysfunction
* Can not be regularly checked
* The adjustment range is less than 8D or obvious near difficulties
* Other reasons researchers think it is not suitable for inclusion in researchers

Where it's running

  • Tianjin Medical University Eye Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.